OS Therapies OSTX
NYSE OSTX
$1.65 +0.04 (+2.44%)
As of: Oct 2, 2026 · 10:21 AM EDT

OS Therapies (OSTX) Net Equity Issued and Repurchased (2025)

Updated

OS Therapies (OSTX) recorded Net Equity Issued and Repurchased of $1.59 million in Q4 2025, down 51.3% from the prior quarter.

Analysis

OS Therapies (OSTX) Net Equity Issued and Repurchased (2025) Analysis & Trends

For FY2025, OS Therapies reported Net Equity Issued and Repurchased of $7.86 million, up 50.4% from FY2024.

  • Across earlier years, Net Equity Issued and Repurchased came in at $5.23 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 OS Therapies 7.73 Mn 7.73 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.59 Mn
Sep 30, 2025 3.27 Mn
API Access

OS Therapies Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=OSTX&period=max&api_key=YOUR_API_KEY